Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Jul 22, 2026 · 10-K · 83 days after period end · 0001214659-26-008832
derived · Computed from the longer spans the company filed.
| Metric | Q4 2026dderived from reported figures | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.87M | -$1.09M | -$851.53K | -$3.31M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Apr 30, 2026 · filed Jul 22, 2026 · 83 d after period end
